{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T19:01:01Z","timestamp":1790794861597,"version":"4.1.0"},"reference-count":135,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,7,12]],"date-time":"2019-07-12T00:00:00Z","timestamp":1562889600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2019,7,12]],"date-time":"2019-07-12T00:00:00Z","timestamp":1562889600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Fresco Institute for Parkinson's and Movement Disorders","award":["not applicable"],"award-info":[{"award-number":["not applicable"]}]},{"name":"Fresco Institute for Parkinson's and Movement Disorders","award":["not applicable"],"award-info":[{"award-number":["not applicable"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["acta neuropathol commun"],"published-print":{"date-parts":[[2019,12]]},"DOI":"10.1186\/s40478-019-0730-6","type":"journal-article","created":{"date-parts":[[2019,7,12]],"date-time":"2019-07-12T08:21:02Z","timestamp":1562919662000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":81,"title":["Understanding the pathogenesis of multiple system atrophy: state of the art and future perspectives"],"prefix":"10.1186","volume":"7","author":[{"given":"Giacomo","family":"Monzio Compagnoni","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6478-026X","authenticated-orcid":false,"given":"Alessio","family":"Di Fonzo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,7,12]]},"reference":[{"issue":"3","key":"730_CR1","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1111\/j.1750-3639.2012.00637.x","volume":"23","author":"Z Ahmed","year":"2013","unstructured":"Ahmed Z, Asi YT, Lees AJ, Revesz T, Holton JL (2013) Identification and quantification of oligodendrocyte precursor cells in multiple system atrophy, progressive supranuclear palsy and Parkinson\u2019s disease. Brain Pathol 23(3):263\u2013273","journal-title":"Brain Pathol"},{"issue":"1","key":"730_CR2","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1111\/j.1471-4159.2006.03731.x","volume":"97","author":"KJ Ahn","year":"2006","unstructured":"Ahn KJ, Paik SR, Chung KC, Kim J (2006) Amino acid sequence motifs and mechanistic features of the membrane translocation of alpha-synuclein. J Neurochem 97(1):265\u2013279","journal-title":"J Neurochem"},{"issue":"6","key":"730_CR3","doi-asserted-by":"publisher","first-page":"964","DOI":"10.1002\/glia.22653","volume":"62","author":"YT Asi","year":"2014","unstructured":"Asi YT, Simpson JE, Heath PR, Wharton SB, Lees AJ, Revesz T et al (2014) Alpha-synuclein mRNA expression in oligodendrocytes in MSA. Glia 62(6):964\u2013970","journal-title":"Glia"},{"issue":"39","key":"730_CR4","doi-asserted-by":"publisher","first-page":"13454","DOI":"10.1523\/JNEUROSCI.1292-12.2012","volume":"32","author":"EJ Bae","year":"2012","unstructured":"Bae EJ, Lee HJ, Rockenstein E, Ho DH, Park EB, Yang NY et al (2012) Antibody-aided clearance of extracellular \u03b1-synuclein prevents cell-to-cell aggregate transmission. J Neurosci 32(39):13454\u201313469","journal-title":"J Neurosci"},{"issue":"7","key":"730_CR5","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1093\/jnen\/nlw037","volume":"75","author":"E Barca","year":"2016","unstructured":"Barca E, Kleiner G, Tang G, Ziosi M, Tadesse S, Masliah E et al (2016) Decreased coenzyme Q10 levels in multiple system atrophy cerebellum. J Neuropathol Exp Neurol 75(7):663\u2013672","journal-title":"J Neuropathol Exp Neurol"},{"issue":"Pt B","key":"730_CR6","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1016\/j.brainres.2015.06.002","volume":"1628","author":"PJ Barrett","year":"2015","unstructured":"Barrett PJ, Timothy Greenamyre J (2015) Post-translational modification of \u03b1-synuclein in Parkinson's disease. Brain Res 1628(Pt B):247\u2013253","journal-title":"Brain Res"},{"issue":"7362","key":"730_CR7","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1038\/nature10324","volume":"477","author":"T Bartels","year":"2011","unstructured":"Bartels T, Choi JG, Selkoe DJ (2011) \u03b1-Synuclein occurs physiologically as a helically folded tetramer that resists aggregation. Nature 477(7362):107\u2013110","journal-title":"Nature"},{"issue":"8","key":"730_CR8","doi-asserted-by":"publisher","first-page":"1230","DOI":"10.1002\/mds.27041","volume":"32","author":"F Bassil","year":"2017","unstructured":"Bassil F, Guerin PA, Dutheil N, Li Q, Klugmann M, Meissner WG et al (2017) Viral-mediated oligodendroglial alpha-synuclein expression models multiple system atrophy. Mov Disord 32(8):1230\u20131239","journal-title":"Mov Disord"},{"issue":"5","key":"730_CR9","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1038\/ng1769","volume":"38","author":"A Bender","year":"2006","unstructured":"Bender A, Krishnan KJ, Morris CM, Taylor GA, Reeve AK, Perry RH et al (2006) High levels of mitochondrial DNA deletions in substantia nigra neurons in aging and Parkinson disease. Nat Genet 38(5):515\u2013517","journal-title":"Nat Genet"},{"issue":"6","key":"730_CR10","doi-asserted-by":"publisher","first-page":"1044","DOI":"10.1016\/j.neuron.2013.09.004","volume":"79","author":"JT Bendor","year":"2013","unstructured":"Bendor JT, Logan TP, Edwards RH (2013) The function of \u03b1-synuclein. Neuron 79(6):1044\u20131066","journal-title":"Neuron"},{"issue":"1","key":"730_CR11","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1007\/s11481-012-9401-0","volume":"8","author":"D B\u00e9raud","year":"2013","unstructured":"B\u00e9raud D, Hathaway HA, Trecki J, Chasovskikh S, Johnson DA, Johnson JA et al (2013) Microglial activation and antioxidant responses induced by the Parkinson\u2019s disease protein \u03b1-synuclein. J NeuroImmune Pharmacol 8(1):94\u2013117","journal-title":"J NeuroImmune Pharmacol"},{"issue":"12","key":"730_CR12","doi-asserted-by":"publisher","first-page":"1301","DOI":"10.1038\/81834","volume":"3","author":"R Betarbet","year":"2000","unstructured":"Betarbet R, Sherer TB, MacKenzie G, Garcia-Osuna M, Panov AV, Greenamyre JT (2000) Chronic systemic pesticide exposure reproduces features of Parkinson's disease. Nat Neurosci 3(12):1301\u20131306","journal-title":"Nat Neurosci"},{"issue":"3","key":"730_CR13","doi-asserted-by":"crossref","first-page":"331","DOI":"10.3233\/JPD-130203","volume":"3","author":"JM Bleasel","year":"2013","unstructured":"Bleasel JM, Hsiao JH, Halliday GM, Kim WS (2013) Increased expression of ABCA8 in multiple system atrophy brain is associated with changes in pathogenic proteins. Parkinsons Dis 3(3):331\u2013339","journal-title":"Parkinsons Dis"},{"key":"730_CR14","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1186\/2051-5960-2-15","volume":"2","author":"JM Bleasel","year":"2014","unstructured":"Bleasel JM, Wong JH, Halliday GM, Kim WS (2014) Lipid dysfunction and pathogenesis of multiple system atrophy. Acta Neuropathol Commun 2:15","journal-title":"Acta Neuropathol Commun"},{"issue":"1","key":"730_CR15","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/0022-510X(94)90248-8","volume":"125","author":"O Blin","year":"1994","unstructured":"Blin O, Desnuelle C, Rascol O, Borg M, Peyro Saint Paul H, Azulay JP et al (1994) Mitochondrial respiratory failure in skeletal muscle from patients with Parkinson\u2019s disease and multiple system atrophy. J Neurol Sci 125(1):95\u2013101","journal-title":"J Neurol Sci"},{"key":"730_CR16","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1016\/j.brainres.2010.02.045","volume":"1326","author":"S Bukhatwa","year":"2010","unstructured":"Bukhatwa S, Zeng BY, Rose S, Jenner P (2010) A comparison of changes in proteasomal subunit expression in the substantia nigra in Parkinson's disease, multiple system atrophy and progressive supranuclear palsy. Brain Res 1326:174\u2013183","journal-title":"Brain Res"},{"issue":"5","key":"730_CR17","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1007\/s11910-015-0549-x","volume":"15","author":"Y Chu","year":"2015","unstructured":"Chu Y, Kordower JH (2015) The prion hypothesis of Parkinson's disease. Curr Neurol Neurosci Rep 15(5):28","journal-title":"Curr Neurol Neurosci Rep"},{"issue":"5","key":"730_CR18","doi-asserted-by":"publisher","first-page":"1479","DOI":"10.1111\/j.1471-4159.2009.06250.x","volume":"110","author":"RL Clough","year":"2009","unstructured":"Clough RL, Dermentzaki G, Stefanis L (2009) Functional dissection of the alpha-synuclein promoter: transcriptional regulation by ZSCAN21 and ZNF219. J Neurochem 110(5):1479\u20131490","journal-title":"J Neurochem"},{"key":"730_CR19","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1016\/j.parkreldis.2017.10.010","volume":"46","author":"Y Compta","year":"2018","unstructured":"Compta Y, Giraldo DM, Mu\u00f1oz E, Antonelli F, Fern\u00e1ndez M, Bravo P et al (2018) Cerebrospinal fluid levels of coenzyme Q10 are reduced in multiple system atrophy. Parkinsonism Relat Disord 46:16\u201323","journal-title":"Parkinsonism Relat Disord"},{"issue":"16","key":"730_CR20","doi-asserted-by":"publisher","first-page":"8756","DOI":"10.1074\/jbc.M115.704973","volume":"291","author":"G Dermentzaki","year":"2016","unstructured":"Dermentzaki G, Paschalidis N, Politis PK, Stefanis L (2016) Complex effects of the ZSCAN21 transcription factor on transcriptional regulation of \u03b1-Synuclein in primary neuronal cultures and in vivo. J Biol Chem 291(16):8756\u20138772","journal-title":"J Biol Chem"},{"issue":"31","key":"730_CR21","doi-asserted-by":"publisher","first-page":"13010","DOI":"10.1073\/pnas.0903691106","volume":"106","author":"P Desplats","year":"2009","unstructured":"Desplats P, Lee HJ, Bae EJ, Patrick C, Rockenstein E, Crews L et al (2009) Inclusion formation and neuronal cell death through neuron-to-neuron transmission of alpha-synuclein. Proc Natl Acad Sci U S A 106(31):13010\u201313015","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"2","key":"730_CR22","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1016\/j.stemcr.2015.07.002","volume":"5","author":"M Djelloul","year":"2015","unstructured":"Djelloul M, Holmqvist S, Boza-Serrano A, Azevedo C, Yeung MS, Goldwurm S et al (2015) Alpha-Synuclein expression in the oligodendrocyte lineage: an in vitro and in vivo study using rodent and human models. Stem Cell Rep 5(2):174\u2013184","journal-title":"Stem Cell Rep"},{"key":"730_CR23","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1186\/s40478-014-0150-6","volume":"2","author":"AS Don","year":"2014","unstructured":"Don AS, Hsiao JH, Bleasel JM, Couttas TA, Halliday GM, Kim WS (2014) Altered lipid levels provide evidence for myelin dysfunction in multiple system atrophy. Acta Neuropathol Commun 2:150","journal-title":"Acta Neuropathol Commun"},{"issue":"17","key":"730_CR24","doi-asserted-by":"publisher","first-page":"12726","DOI":"10.1074\/jbc.M109.086827","volume":"285","author":"E Doxakis","year":"2010","unstructured":"Doxakis E (2010) Post-transcriptional regulation of alpha-synuclein expression by mir-7 and mir-153. J Biol Chem 285(17):12726\u201312734","journal-title":"J Biol Chem"},{"issue":"1","key":"730_CR25","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1007\/s00401-016-1572-y","volume":"132","author":"B Ettle","year":"2016","unstructured":"Ettle B, Kerman BE, Valera E, Gillmann C, Schlachetzki JC, Reiprich S et al (2016) \u03b1-Synuclein-induced myelination deficit defines a novel interventional target for multiple system atrophy. Acta Neuropathol 132(1):59\u201375","journal-title":"Acta Neuropathol"},{"key":"730_CR26","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1016\/j.mcn.2014.06.012","volume":"62","author":"B Ettle","year":"2014","unstructured":"Ettle B, Reiprich S, Deusser J, Schlachetzki JC, Xiang W, Prots I et al (2014) Intracellular alpha-synuclein affects early maturation of primary oligodendrocyte progenitor cells. Mol Cell Neurosci 62:68\u201378","journal-title":"Mol Cell Neurosci"},{"issue":"3","key":"730_CR27","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1056\/NEJMra1311488","volume":"372","author":"A Fanciulli","year":"2015","unstructured":"Fanciulli A, Wenning GK (2015) Multiple-system atrophy. N Engl J Med 372(3):249\u2013263","journal-title":"N Engl J Med"},{"issue":"19","key":"730_CR28","doi-asserted-by":"publisher","first-page":"15345","DOI":"10.1074\/jbc.M111.318949","volume":"287","author":"B Fauvet","year":"2012","unstructured":"Fauvet B, Mbefo MK, Fares MB, Desobry C, Michael S, Ardah MT et al (2012) \u03b1-Synuclein in central nervous system and from erythrocytes, mammalian cells, and Escherichia coli exists predominantly as disordered monomer. J Biol Chem 287(19):15345\u201315364","journal-title":"J Biol Chem"},{"issue":"4","key":"730_CR29","doi-asserted-by":"publisher","first-page":"1005","DOI":"10.1016\/S0306-4522(02)00205-1","volume":"114","author":"PO Fernagut","year":"2002","unstructured":"Fernagut PO, Diguet E, Stefanova N, Biran M, Wenning GK, Canioni P et al (2002) Subacute systemic 3-nitropropionic acid intoxication induces a distinct motor disorder in adult C57Bl\/6 mice: behavioural and histopathological characterisation. Neuroscience 114(4):1005\u20131017","journal-title":"Neuroscience"},{"issue":"7","key":"730_CR30","doi-asserted-by":"publisher","first-page":"829","DOI":"10.1093\/eurheartj\/ehr304","volume":"33","author":"U F\u00f6rstermann","year":"2012","unstructured":"F\u00f6rstermann U, Sessa WC (2012) Nitric oxide synthases: regulation and function. Eur Heart J 33(7):829\u2013837 837a, 837d","journal-title":"Eur Heart J"},{"issue":"28","key":"730_CR31","doi-asserted-by":"publisher","first-page":"9441","DOI":"10.1523\/JNEUROSCI.5314-13.2014","volume":"34","author":"D Games","year":"2014","unstructured":"Games D, Valera E, Spencer B, Rockenstein E, Mante M, Adame A et al (2014) Reducing C-terminal-truncated alpha-synuclein by immunotherapy attenuates neurodegeneration and propagation in Parkinson's disease-like models. J Neurosci 34(28):9441\u20139454","journal-title":"J Neurosci"},{"issue":"12","key":"730_CR32","doi-asserted-by":"publisher","first-page":"1687","DOI":"10.1007\/s00702-005-0381-6","volume":"112","author":"S Gilman","year":"2005","unstructured":"Gilman S, May SJ, Shults CW, Tanner CM, Kukull W, Lee VM et al (2005) The north American multiple system atrophy study group. J Neural Transm (Vienna) 112(12):1687\u20131694","journal-title":"J Neural Transm (Vienna)"},{"issue":"9","key":"730_CR33","doi-asserted-by":"publisher","first-page":"670","DOI":"10.1212\/01.wnl.0000324625.00404.15","volume":"71","author":"S Gilman","year":"2008","unstructured":"Gilman S, Wenning GK, Low PA, Brooks DJ, Mathias CJ, Trojanowski JQ et al (2008) Second consensus statement on the diagnosis of multiple system atrophy. Neurology 71(9):670\u2013676","journal-title":"Neurology"},{"issue":"7","key":"730_CR34","doi-asserted-by":"publisher","first-page":"634","DOI":"10.1093\/jnen\/61.7.634","volume":"61","author":"G Gu","year":"2002","unstructured":"Gu G, Reyes PE, Golden GT, Woltjer RL, Hulette C, Montine TJ, Zhang J (2002) Mitochondrial DNA deletions\/rearrangements in parkinson disease and related neurodegenerative disorders. J Neuropathol Exp Neurol 61(7):634\u2013639","journal-title":"J Neuropathol Exp Neurol"},{"issue":"3","key":"730_CR35","doi-asserted-by":"publisher","first-page":"418","DOI":"10.1002\/mds.870120323","volume":"12","author":"M Gu","year":"1997","unstructured":"Gu M, Gash MT, Cooper JM, Wenning GK, Daniel SE, Quinn NP et al (1997) Mitochondrial respiratory chain function in multiple system atrophy. Mov Disord 12(3):418\u2013422","journal-title":"Mov Disord"},{"issue":"6","key":"730_CR36","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1007\/s004010051177","volume":"99","author":"K Gwinn-Hardy","year":"2000","unstructured":"Gwinn-Hardy K, Mehta ND, Farrer M, Maraganore D, Muenter M, Yen SH et al (2000) Distinctive neuropathology revealed by alpha-synuclein antibodies in hereditary parkinsonism and dementia linked to chromosome 4p. Acta Neuropathol 99(6):663\u2013672","journal-title":"Acta Neuropathol"},{"issue":"2","key":"730_CR37","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1172\/JCI43366","volume":"121","author":"C Hansen","year":"2011","unstructured":"Hansen C, Angot E, Bergstr\u00f6m AL, Steiner JA, Pieri L, Paul G et al (2011) \u03b1-Synuclein propagates from mouse brain to grafted dopaminergic neurons and seeds aggregation in cultured human cells. J Clin Invest 121(2):715\u2013725","journal-title":"J Clin Invest"},{"issue":"8","key":"730_CR38","doi-asserted-by":"publisher","first-page":"857","DOI":"10.1016\/j.neuint.2010.09.002","volume":"57","author":"T Hasegawa","year":"2010","unstructured":"Hasegawa T, Baba T, Kobayashi M, Konno M, Sugeno N, Kikuchi A et al (2010) Role of TPPP\/p25 on \u03b1-synuclein-mediated oligodendroglial degeneration and the protective effect of SIRT2 inhibition in a cellular model of multiple system atrophy. Neurochem Int 57(8):857\u2013866","journal-title":"Neurochem Int"},{"issue":"6","key":"730_CR39","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1007\/s004010050655","volume":"93","author":"M Inoue","year":"1997","unstructured":"Inoue M, Yagishita S, Ryo M, Hasegawa K, Amano N, Matsushita M (1997) The distribution and dynamic density of oligodendroglial cytoplasmic inclusions (GCIs) in multiple system atrophy: a correlation between the density of GCIs and the degree of involvement of striatonigral and olivopontocerebellar systems. Acta Neuropathol 93(6):585\u2013591","journal-title":"Acta Neuropathol"},{"issue":"1","key":"730_CR40","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1093\/jnen\/63.1.43","volume":"63","author":"K Ishizawa","year":"2004","unstructured":"Ishizawa K, Komori T, Sasaki S, Arai N, Mizutani T, Hirose T (2004) Microglial activation parallels system degeneration in multiple system atrophy. J Neuropathol Exp Neurol 63(1):43\u201352","journal-title":"J Neuropathol Exp Neurol"},{"issue":"14","key":"730_CR41","doi-asserted-by":"publisher","first-page":"1720","DOI":"10.1002\/mds.26052","volume":"29","author":"KA Jellinger","year":"2014","unstructured":"Jellinger KA (2014) Neuropathology of multiple system atrophy: new thoughts about pathogenesis. Mov Disord 29(14):1720\u20131741","journal-title":"Mov Disord"},{"issue":"3","key":"730_CR42","doi-asserted-by":"publisher","first-page":"1141","DOI":"10.3233\/JAD-170397","volume":"62","author":"KA Jellinger","year":"2018","unstructured":"Jellinger KA (2018) Multiple system atrophy: An Oligodendroglioneural Synucleinopathy. J Alzheimers Dis 62(3):1141\u20131179","journal-title":"J Alzheimers Dis"},{"issue":"6","key":"730_CR43","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1007\/s00401-010-0672-3","volume":"119","author":"KA Jellinger","year":"2010","unstructured":"Jellinger KA, Lantos PL (2010) Papp-Lantos inclusions and the pathogenesis of multiple system atrophy: an update. Acta Neuropathol 119(6):657\u2013667","journal-title":"Acta Neuropathol"},{"issue":"6","key":"730_CR44","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1007\/s00702-016-1545-2","volume":"123","author":"KA Jellinger","year":"2016","unstructured":"Jellinger KA, Wenning GK (2016) Multiple system atrophy: pathogenic mechanisms and biomarkers. J Neural Transm (Vienna) 123(6):555\u2013572","journal-title":"J Neural Transm (Vienna)"},{"issue":"1","key":"730_CR45","first-page":"145","volume":"55","author":"H Jin","year":"2008","unstructured":"Jin H, Ishikawa K, Tsunemi T, Ishiguro T, Amino T, Mizusawa H (2008) Analyses of copy number and mRNA expression level of the alpha-synuc lein gene in multiple system atrophy. J Med Dent Sci 55(1):145\u2013153","journal-title":"J Med Dent Sci"},{"issue":"18","key":"730_CR46","doi-asserted-by":"publisher","first-page":"6355","DOI":"10.1523\/JNEUROSCI.6119-09.2010","volume":"30","author":"A Jowaed","year":"2010","unstructured":"Jowaed A, Schmitt I, Kaut O, W\u00fcllner U (2010) Methylation regulates alpha-synuclein expression and is decreased in Parkinson's disease patients\u2019 brains. J Neurosci 30(18):6355\u20136359","journal-title":"J Neurosci"},{"issue":"31","key":"730_CR47","doi-asserted-by":"publisher","first-page":"13052","DOI":"10.1073\/pnas.0906277106","volume":"106","author":"E Junn","year":"2009","unstructured":"Junn E, Lee KW, Jeong BS, Chan TW, Im JY, Mouradian MM (2009) Repression of alpha-synuclein expression and toxicity by microRNA-7. Proc Natl Acad Sci U S A 106(31):13052\u201313057","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"6","key":"730_CR48","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1093\/embo-reports\/kvf109","volume":"3","author":"PJ Kahle","year":"2002","unstructured":"Kahle PJ, Neumann M, Ozmen L, Muller V, Jacobsen H, Spooren W et al (2002) Hyperphosphorylation and insolubility of \u03b1-synuclein in transgenic mouse oligodendrocytes. EMBO Rep 3(6):583\u2013588","journal-title":"EMBO Rep"},{"issue":"4","key":"730_CR49","doi-asserted-by":"publisher","first-page":"1253","DOI":"10.3233\/JAD-170601","volume":"61","author":"C Kaindlstorfer","year":"2018","unstructured":"Kaindlstorfer C, Jellinger KA, Eschlb\u00f6ck S, Stefanova N, Weiss G, Wenning GK (2018) The relevance of Iron in the pathogenesis of multiple system atrophy: a viewpoint. J Alzheimers Dis 61(4):1253\u20131273","journal-title":"J Alzheimers Dis"},{"issue":"2","key":"730_CR50","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1016\/j.stemcr.2017.12.001","volume":"10","author":"S Kaji","year":"2018","unstructured":"Kaji S, Maki T, Kinoshita H, Uemura N, Ayaki T, Kawamoto Y et al (2018) Pathological endogenous \u03b1-Synuclein accumulation in oligodendrocyte precursor cells potentially induces inclusions in multiple system atrophy. Stem Cell Rep 10(2):356\u2013365","journal-title":"Stem Cell Rep"},{"issue":"7","key":"730_CR51","doi-asserted-by":"publisher","first-page":"971","DOI":"10.1038\/s41374-019-0195-z","volume":"99","author":"Richard J. Karpowicz","year":"2019","unstructured":"Karpowicz RJ Jr, Trojanowski JQ, Lee VM (2019) Transmission of \u03b1-synuclein seeds in neurodegenerative disease: recent developments. Lab Investig. \n                    https:\/\/doi.org\/10.1038\/s41374-019-0195-z","journal-title":"Laboratory Investigation"},{"issue":"1","key":"730_CR52","doi-asserted-by":"publisher","first-page":"e0147574","DOI":"10.1371\/journal.pone.0147574","volume":"11","author":"T Kasai","year":"2016","unstructured":"Kasai T, Tokuda T, Ohmichi T, Ishii R, Tatebe H, Nakagawa M, Mizuno T (2016) Serum levels of coenzyme Q10 in patients with multiple system atrophy. PLoS One 11(1):e0147574","journal-title":"PLoS One"},{"issue":"10","key":"730_CR53","doi-asserted-by":"publisher","first-page":"984","DOI":"10.1097\/NEN.0b013e31818809f4","volume":"67","author":"Y Kawamoto","year":"2008","unstructured":"Kawamoto Y, Kobayashi Y, Suzuki Y, Inoue H, Tomimoto H, Akiguchi I et al (2008) Accumulation of HtrA2\/Omi in neuronal and glial inclusions in brains with alpha-synucleinopathies. J Neuropathol Exp Neurol 67(10):984\u2013993","journal-title":"J Neuropathol Exp Neurol"},{"issue":"10","key":"730_CR54","doi-asserted-by":"publisher","first-page":"e46817","DOI":"10.1371\/journal.pone.0046817","volume":"7","author":"H Kisos","year":"2012","unstructured":"Kisos H, Puka\u00df K, Ben-Hur T, Richter-Landsberg C, Sharon R (2012) Increased neuronal \u03b1-synuclein pathology associates with its accumulation in oligodendrocytes in mice modeling \u03b1-synucleinopathies. PLoS One 7(10):e46817","journal-title":"PLoS One"},{"issue":"15","key":"730_CR55","doi-asserted-by":"publisher","first-page":"2604","DOI":"10.1002\/mds.23192","volume":"25","author":"M K\u00f6llensperger","year":"2010","unstructured":"K\u00f6llensperger M, Geser F, Ndayisaba JP, Boesch S, Seppi K, Ostergaard K et al (2010) Presentation, diagnosis, and management of multiple system atrophy in Europe: final analysis of the European multiple system atrophy registry. Mov Disord 25(15):2604\u20132612","journal-title":"Mov Disord"},{"key":"730_CR56","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1186\/1750-1326-7-38","volume":"7","author":"M Konno","year":"2012","unstructured":"Konno M, Hasegawa T, Baba T, Miura E, Sugeno N, Kikuchi A et al (2012) Suppression of dynamin GTPase decreases \u03b1-synuclein uptake by neuronal and oligodendroglial cells: a potent therapeutic target for synucleinopathy. Mol Neurodegener 7:38","journal-title":"Mol Neurodegener"},{"issue":"1","key":"730_CR57","doi-asserted-by":"publisher","first-page":"e55243","DOI":"10.1371\/journal.pone.0055243","volume":"8","author":"CL Kragh","year":"2013","unstructured":"Kragh CL, Fillon G, Gysbers A, Hansen DH, Neumann M, Richter-Landsberg C et al (2013) FAS-dependent cell death in \u03b1-synuclein transgenic oligodendrocyte models of multiple system atrophy. PLoS One 8(1):e55243","journal-title":"PLoS One"},{"issue":"4","key":"730_CR58","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1038\/nrneurol.2017.26","volume":"13","author":"F Krismer","year":"2017","unstructured":"Krismer F, Wenning GK (2017) Multiple system atrophy: insights into a rare and debilitating movement disorder. Nat Rev Neurol 13(4):232\u2013243","journal-title":"Nat Rev Neurol"},{"issue":"8","key":"730_CR59","doi-asserted-by":"publisher","first-page":"917","DOI":"10.1001\/jamaneurol.2016.1810","volume":"73","author":"SH Kuo","year":"2016","unstructured":"Kuo SH, Quinzii MC (2016) Coenzyme Q10 as a peripheral biomarker for multiple system atrophy. JAMA Neurol 73(8):917\u2013919","journal-title":"JAMA Neurol"},{"issue":"6","key":"730_CR60","doi-asserted-by":"publisher","first-page":"766","DOI":"10.1002\/mds.21259","volume":"22","author":"AJ Langerveld","year":"2007","unstructured":"Langerveld AJ, Mihalko D, DeLong C, Walburn J, Ide CF (2007) Gene expression changes in postmortem tissue from the rostral pons of multiple system atrophy patients. Mov Disord 22(6):766\u2013777","journal-title":"Mov Disord"},{"issue":"1","key":"730_CR61","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1038\/nrn3406","volume":"14","author":"HA Lashuel","year":"2013","unstructured":"Lashuel HA, Overk CR, Oueslati A, Masliah E (2013) The many faces of \u03b1-synuclein: from structure and toxicity to therapeutic target. Nat Rev Neurosci 14(1):38\u201348","journal-title":"Nat Rev Neurosci"},{"issue":"9","key":"730_CR62","doi-asserted-by":"publisher","first-page":"1835","DOI":"10.1016\/j.biocel.2008.01.017","volume":"40","author":"HJ Lee","year":"2008","unstructured":"Lee HJ, Suk JE, Bae EJ, Lee JH, Paik SR, Lee SJ (2008) Assembly-dependent endocytosis and clearance of extracellular alpha-synuclein. Int J Biochem Cell Biol 40(9):1835\u20131849","journal-title":"Int J Biochem Cell Biol"},{"issue":"3","key":"730_CR63","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1002\/mds.26138","volume":"30","author":"CH Lin","year":"2015","unstructured":"Lin CH, Tan EK, Yang CC, Yi Z, Wu RM (2015) COQ2 gene variants associate with cerebellar subtype of multiple system atrophy in Chinese. Mov Disord 30(3):436\u2013437","journal-title":"Mov Disord"},{"issue":"2","key":"730_CR64","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1515\/hsz-2013-0241","volume":"395","author":"J Lugrin","year":"2014","unstructured":"Lugrin J, Rosenblatt-Velin N, Parapanov R, Liaudet L (2014) The role of oxidative stress during inflammatory processes. Biol Chem 395(2):203\u2013230","journal-title":"Biol Chem"},{"issue":"5","key":"730_CR65","doi-asserted-by":"publisher","first-page":"975","DOI":"10.1084\/jem.20112457","volume":"209","author":"KC Luk","year":"2012","unstructured":"Luk KC, Kehm VM, Zhang B, O'Brien P, Trojanowski JQ, Lee VM (2012) Intracerebral inoculation of pathological \u03b1-synuclein initiates a rapidly progressive neurodegenerative \u03b1-synucleinopathy in mice. J Exp Med 209(5):975\u2013986","journal-title":"J Exp Med"},{"key":"730_CR66","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1186\/s40478-017-0451-7","volume":"5","author":"RJ Mandel","year":"2017","unstructured":"Mandel RJ, Marmion DJ, Kirik D, Chu Y, Heindel C, McCown T et al (2017) Novel oligodendroglial alpha synuclein viral vector models of multiple system atrophy: studies in rodents and nonhuman primates. Acta Neuropathol Commun 5:47","journal-title":"Acta Neuropathol Commun"},{"key":"730_CR67","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1186\/s13024-015-0008-9","volume":"10","author":"M Mandler","year":"2015","unstructured":"Mandler M, Valera E, Rockenstein E, Mante M, Weninger H, Patrick C et al (2015) Active immunization against alpha-synuclein ameliorates the degenerative pathology and prevents demyelination in a model of multiple system atrophy. Mol Neurodegener 10:10","journal-title":"Mol Neurodegener"},{"issue":"6","key":"730_CR68","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1007\/s00401-014-1256-4","volume":"127","author":"M Mandler","year":"2014","unstructured":"Mandler M, Valera E, Rockenstein E, Weninger H, Patrick C, Adame A et al (2014) Next-generation active immunization approach for synucleinopathies: implications for Parkinson\u2019s disease clinical trials. Acta Neuropathol 127(6):861\u2013879","journal-title":"Acta Neuropathol"},{"issue":"4","key":"730_CR69","doi-asserted-by":"publisher","first-page":"e19338","DOI":"10.1371\/journal.pone.0019338","volume":"6","author":"E Masliah","year":"2011","unstructured":"Masliah E, Rockenstein E, Mante M, Crews L, Spencer B, Adame A et al (2011) Passive immunization reduces behavioral and neuropathological deficits in an alpha-synuclein transgenic model of Lewy body disease. PLoS One 6(4):e19338","journal-title":"PLoS One"},{"issue":"11","key":"730_CR70","doi-asserted-by":"publisher","first-page":"e15522","DOI":"10.1371\/journal.pone.0015522","volume":"5","author":"L Matsumoto","year":"2010","unstructured":"Matsumoto L, Takuma H, Tamaoka A, Kurisaki H, Date H, Tsuji S, Iwata A (2010) CpG demethylation enhances alpha-synuclein expression and affects the pathogenesis of Parkinson's disease. PLoS One 5(11):e15522","journal-title":"PLoS One"},{"issue":"10","key":"730_CR71","doi-asserted-by":"publisher","first-page":"2357","DOI":"10.1016\/j.neurobiolaging.2014.02.028","volume":"35","author":"VE May","year":"2014","unstructured":"May VE, Ettle B, Poehler AM, Nuber S, Ubhi K, Rockenstein E et al (2014) \u03b1-Synuclein impairs oligodendrocyte progenitor maturation in multiple system atrophy. Neurobiol Aging 35(10):2357\u20132368","journal-title":"Neurobiol Aging"},{"issue":"12","key":"730_CR72","doi-asserted-by":"publisher","first-page":"1613","DOI":"10.1007\/s00702-005-0378-1","volume":"112","author":"DW Miller","year":"2005","unstructured":"Miller DW, Johnson JM, Solano SM, Hollingsworth ZR, Standaert DG, Young AB (2005) Absence of alpha-synuclein mRNA expression in normal and multiple system atrophy oligodendroglia. J Neural Transm (Vienna) 112(12):1613\u20131624","journal-title":"J Neural Transm (Vienna)"},{"issue":"8","key":"730_CR73","doi-asserted-by":"publisher","first-page":"977","DOI":"10.1001\/jamaneurol.2016.1325","volume":"73","author":"J Mitsui","year":"2016","unstructured":"Mitsui J, Matsukawa T, Yasuda T, Ishiura H, Tsuji S (2016) Plasma coenzyme Q10 levels in patients with multiple system atrophy. JAMA Neurol 73(8):977\u2013980","journal-title":"JAMA Neurol"},{"issue":"11","key":"730_CR74","doi-asserted-by":"publisher","first-page":"711","DOI":"10.1038\/jhg.2013.90","volume":"58","author":"I Mizuta","year":"2013","unstructured":"Mizuta I, Takafuji K, Ando Y, Satake W, Kanagawa M, Kobayashi K et al (2013) YY1 binds to \u03b1-synuclein 3\u2032-flanking region SNP and stimulates antisense noncoding RNA expression. J Hum Genet 58(11):711\u2013719","journal-title":"J Hum Genet"},{"issue":"12","key":"730_CR75","doi-asserted-by":"publisher","first-page":"3588","DOI":"10.1016\/j.bbadis.2018.09.018","volume":"1864","author":"G Monzio Compagnoni","year":"2018","unstructured":"Monzio Compagnoni G, Kleiner G, Bordoni A, Fortunato F, Ronchi D, Salani S et al (2018) Mitochondrial dysfunction in fibroblasts of multiple system atrophy. Biochim Biophys Acta Mol basis Dis 1864(12):3588\u20133597","journal-title":"Biochim Biophys Acta Mol basis Dis"},{"issue":"5","key":"730_CR76","doi-asserted-by":"publisher","first-page":"1185","DOI":"10.1016\/j.stemcr.2018.09.007","volume":"11","author":"G Monzio Compagnoni","year":"2018","unstructured":"Monzio Compagnoni G, Kleiner G, Samarani M, Aureli M, Faustini G, Bellucci A et al (2018) Mitochondrial dysregulation and impaired autophagy in iPSC-derived dopaminergic neurons of multiple system atrophy. Stem Cell Rep 11(5):1185\u20131198","journal-title":"Stem Cell Rep"},{"issue":"3","key":"730_CR77","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1056\/NEJMoa1212115","volume":"369","author":"Multiple-System Atrophy Research Collaboration","year":"2013","unstructured":"Multiple-System Atrophy Research Collaboration (2013) Mutations in COQ2 in familial and sporadic multiple-system atrophy. N Engl J Med 369(3):233\u2013244","journal-title":"N Engl J Med"},{"issue":"1","key":"730_CR78","doi-asserted-by":"publisher","first-page":"14215","DOI":"10.1038\/s41598-018-32573-1","volume":"8","author":"FK Nakamoto","year":"2018","unstructured":"Nakamoto FK, Okamoto S, Mitsui J, Sone T, Ishikawa M, Yamamoto Y et al (2018) The pathogenesis linked to coenzyme Q10 insufficiency in iPSC-derived neurons from patients with multiple-system atrophy. Sci Rep 8(1):14215","journal-title":"Sci Rep"},{"key":"730_CR79","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1186\/1750-1326-9-44","volume":"9","author":"K Ogaki","year":"2014","unstructured":"Ogaki K, Fujioka S, Heckman MG, Rayaprolu S, Soto-Ortolaza AI, Labb\u00e9 C et al (2014) Analysis of COQ2 gene in multiple system atrophy. Mol Neurodegener 9:44","journal-title":"Mol Neurodegener"},{"key":"730_CR80","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1016\/S0079-6123(10)83007-9","volume":"183","author":"A Oueslati","year":"2010","unstructured":"Oueslati A, Fournier M, Lashuel HA (2010) Role of post-translational modifications in modulating the structure, function and toxicity of alpha-synuclein: implications for Parkinson's disease pathogenesis and therapies. Prog Brain Res 183:115\u2013145","journal-title":"Prog Brain Res"},{"issue":"2","key":"730_CR81","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1007\/s004010100367","volume":"102","author":"T Ozawa","year":"2001","unstructured":"Ozawa T, Okuizumi K, Ikeuchi T, Wakabayashi K, Takahashi H, Tsuji S (2001) Analysis of the expression level of alpha-synuclein mRNA using postmortem brain samples from pathologically confirmed cases of multiple system atrophy. Acta Neuropathol 102(2):188\u2013190","journal-title":"Acta Neuropathol"},{"key":"730_CR82","doi-asserted-by":"publisher","first-page":"2657","DOI":"10.1093\/brain\/awh303","volume":"127","author":"T Ozawa","year":"2004","unstructured":"Ozawa T, Paviour D, Quinn NP, Josephs KA, Sangha H, Kilford L et al (2004) The spectrum of pathological involvement of the striatonigral and olivopontocerebellar systems in multiple system atrophy: clinicopathological correlations. Brain 127(Pt 12:2657\u20132671","journal-title":"Brain"},{"issue":"1","key":"730_CR83","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1007\/s10286-014-0249-7","volume":"25","author":"JA Palma","year":"2015","unstructured":"Palma JA, Kaufmann H (2015) Novel therapeutic approaches in multiple system atrophy. Clin Auton Res 25(1):37\u201345","journal-title":"Clin Auton Res"},{"issue":"1\u20133","key":"730_CR84","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/0022-510X(89)90219-0","volume":"94","author":"MI Papp","year":"1989","unstructured":"Papp MI, Kahn JE, Lantos PL (1989) Glial cytoplasmic inclusions in the CNS of patients with multiple system atrophy (striatonigral degeneration, olivopontocerebellar atrophy and shy-Drager syndrome). J Neurol Sci 94(1\u20133):79\u2013100","journal-title":"J Neurol Sci"},{"issue":"Pt 2","key":"730_CR85","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1093\/brain\/117.2.235","volume":"117","author":"MI Papp","year":"1994","unstructured":"Papp MI, Lantos PL (1994) The distribution of oligodendroglial inclusions in multiple system atrophy and its relevance to clinical symptomatology. Brain 117(Pt 2):235\u2013243","journal-title":"Brain"},{"issue":"7556","key":"730_CR86","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1038\/nature14547","volume":"522","author":"W Peelaerts","year":"2015","unstructured":"Peelaerts W, Bousset L, Van der Perren A, Moskalyuk A, Pulizzi R, Giugliano M et al (2015) \u03b1-Synuclein strains cause distinct synucleinopathies after local and systemic administration. Nature 522(7556):340\u2013344","journal-title":"Nature"},{"issue":"7706","key":"730_CR87","doi-asserted-by":"publisher","first-page":"558","DOI":"10.1038\/s41586-018-0104-4","volume":"557","author":"C Peng","year":"2018","unstructured":"Peng C, Gathagan RJ, Covell DJ, Medellin C, Stieber A, Robinson JL et al (2018) Cellular milieu imparts distinct pathological \u03b1-synuclein strains in \u03b1-synucleinopathies. Nature 557(7706):558\u2013563","journal-title":"Nature"},{"issue":"38","key":"730_CR88","doi-asserted-by":"publisher","first-page":"E5308","DOI":"10.1073\/pnas.1514475112","volume":"112","author":"SB Prusiner","year":"2015","unstructured":"Prusiner SB, Woerman AL, Mordes DA, Watts JC, Rampersaud R, Berry DB et al (2015) Evidence for \u03b1-synuclein prions causing multiple system atrophy in humans with parkinsonism. Proc Natl Acad Sci U S A 112(38):E5308\u2013E5317","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"2","key":"730_CR89","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1086\/500092","volume":"78","author":"C Quinzii","year":"2006","unstructured":"Quinzii C, Naini A, Salviati L, Trevisson E, Navas P, Dimauro S, Hirano M (2006) A mutation in Para-hydroxybenzoate-polyprenyl transferase (COQ2) causes primary coenzyme Q10 deficiency. Am J Hum Genet 78(2):345\u2013349","journal-title":"Am J Hum Genet"},{"issue":"5","key":"730_CR90","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1002\/biof.155","volume":"37","author":"CM Quinzii","year":"2011","unstructured":"Quinzii CM, Hirano M (2011) Primary and secondary CoQ(10) deficiencies in humans. Biofactors 37(5):361\u2013365","journal-title":"Biofactors"},{"issue":"1","key":"730_CR91","first-page":"81","volume":"371","author":"CM Quinzii","year":"2014","unstructured":"Quinzii CM, Hirano M, DiMauro S (2014) Mutant COQ2 in multiple-system atrophy. N Engl J Med 371(1):81\u201382","journal-title":"N Engl J Med"},{"issue":"3","key":"730_CR92","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1002\/glia.22611","volume":"62","author":"JF Reyes","year":"2014","unstructured":"Reyes JF, Rey NL, Bousset L, Melki R, Brundin P, Angot E (2014) Alpha-synuclein transfers from neurons to oligodendrocytes. Glia 62(3):387\u2013398","journal-title":"Glia"},{"issue":"1","key":"730_CR93","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1002\/1097-4547(20001001)62:1<9::AID-JNR2>3.0.CO;2-U","volume":"62","author":"C Richter-Landsberg","year":"2000","unstructured":"Richter-Landsberg C, Gorath M, Trojanowski JQ, Lee VM (2000) Alpha-synuclein is developmentally expressed in cultured rat brain oligodendrocytes. J Neurosci Res 62(1):9\u201314","journal-title":"J Neurosci Res"},{"issue":"Pt B","key":"730_CR94","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1016\/j.nbd.2017.04.004","volume":"109","author":"EM Rocha","year":"2018","unstructured":"Rocha EM, De Miranda B, Sanders LH (2018) Alpha-synuclein: pathology, mitochondrial dysfunction and neuroinflammation in Parkinson's disease. Neurobiol Dis 109(Pt B):249\u2013257","journal-title":"Neurobiol Dis"},{"issue":"4","key":"730_CR95","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1097\/WNR.0b013e3283509842","volume":"23","author":"E Rockenstein","year":"2012","unstructured":"Rockenstein E, Ubhi K, Inglis C, Mante M, Patrick C, Adame A, Masliah E (2012) Neuronal to oligodendroglial alpha-synuclein redistribution in a double transgenic model of MSA. Neuroreport 23(4):259\u2013264","journal-title":"Neuroreport"},{"key":"730_CR96","doi-asserted-by":"publisher","first-page":"213.e1","DOI":"10.1016\/j.neurobiolaging.2016.05.022","volume":"45","author":"D Ronchi","year":"2016","unstructured":"Ronchi D, Di Biase E, Franco G, Melzi V, Del Sorbo F, Elia A et al (2016) Mutational analysis of COQ2 in patients with MSA in Italy. Neurobiol Aging 45:213.e1\u2013213.e2","journal-title":"Neurobiol Aging"},{"issue":"5","key":"730_CR97","doi-asserted-by":"publisher","first-page":"738","DOI":"10.1002\/mds.21385","volume":"22","author":"K Sato","year":"2007","unstructured":"Sato K, Kaji R, Matsumoto S, Goto S (2007) Cell type-specific neuronal loss in the putamen of patients with multiple system atrophy. Mov Disord 22(5):738\u2013742","journal-title":"Mov Disord"},{"issue":"1","key":"730_CR98","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1016\/S1474-4422(07)70327-7","volume":"7","author":"AH Schapira","year":"2008","unstructured":"Schapira AH (2008) Mitochondria in the aetiology and pathogenesis of Parkinson's disease. Lancet Neurol 7(1):97\u2013109","journal-title":"Lancet Neurol"},{"issue":"8649","key":"730_CR99","doi-asserted-by":"publisher","first-page":"1269","DOI":"10.1016\/S0140-6736(89)92366-0","volume":"1","author":"AH Schapira","year":"1989","unstructured":"Schapira AH, Cooper JM, Dexter D, Jenner P, Clark JB, Marsden CD (1989) Mitochondrial complex I deficiency in Parkinson's disease. Lancet 1(8649):1269","journal-title":"Lancet"},{"issue":"31","key":"730_CR100","doi-asserted-by":"publisher","first-page":"10907","DOI":"10.1073\/pnas.0802437105","volume":"105","author":"CR Scherzer","year":"2008","unstructured":"Scherzer CR, Grass JA, Liao Z, Pepivani I, Zheng B, Eklund AC et al (2008) GATA transcription factors directly regulate the Parkinson's disease-linked gene alpha-synuclein. Proc Natl Acad Sci U S A 105(31):10907\u201310912","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"2","key":"730_CR101","doi-asserted-by":"publisher","first-page":"e0149557","DOI":"10.1371\/journal.pone.0149557","volume":"11","author":"LV Schottlaender","year":"2016","unstructured":"Schottlaender LV, Bettencourt C, Kiely AP, Chalasani A, Neergheen V, Holton JL et al (2016) Coenzyme Q10 levels are decreased in the cerebellum of multiple-system atrophy patients. PLoS One 11(2):e0149557","journal-title":"PLoS One"},{"issue":"1","key":"730_CR102","first-page":"81","volume":"371","author":"LV Schottlaender","year":"2014","unstructured":"Schottlaender LV, Houlden H, Multiple-System Atrophy (MSA) Brain Bank Collaboration (2014) Mutant COQ2 in multiple-system atrophy. N Engl J Med 371(1):81","journal-title":"N Engl J Med"},{"issue":"2","key":"730_CR103","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1007\/s12031-012-9733-5","volume":"47","author":"L Schwarz","year":"2012","unstructured":"Schwarz L, Goldbaum O, Bergmann M, Probst-Cousin S, Richter-Landsberg C (2012) Involvement of macroautophagy in multiple system atrophy and protein aggregate formation in oligodendrocytes. J Mol Neurosci 47(2):256\u2013266","journal-title":"J Mol Neurosci"},{"issue":"1","key":"730_CR104","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1056\/NEJMc1311763","volume":"371","author":"M Sharma","year":"2014","unstructured":"Sharma M, Wenning G, Kr\u00fcger R, European multiple-system atrophy study group (EMSA-SG) (2014) Mutant COQ2 in multiple-system atrophy. N Engl J Med 371(1):80\u201381","journal-title":"N Engl J Med"},{"issue":"46","key":"730_CR105","doi-asserted-by":"publisher","first-page":"10689","DOI":"10.1523\/JNEUROSCI.3527-05.2005","volume":"25","author":"CW Shults","year":"2005","unstructured":"Shults CW, Rockenstein E, Crews L, Adame A, Mante M, Larrea G et al (2005) Neurological and neurodegenerative alterations in a transgenic mouse model expressing human alpha-synuclein under oligodendrocyte promoter: implications for multiple system atrophy. J Neurosci 25(46):10689\u201310699","journal-title":"J Neurosci"},{"issue":"3","key":"730_CR106","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1042\/bj2350785","volume":"235","author":"TP Singer","year":"1986","unstructured":"Singer TP, Salach JI, Castagnoli N Jr, Trevor A (1986) Interactions of the neurotoxic amine 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine with monoamine oxidases. Biochem J 235(3):785\u2013789","journal-title":"Biochem J"},{"issue":"2","key":"730_CR107","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1002\/1531-8249(200002)47:2<201::AID-ANA10>3.0.CO;2-F","volume":"47","author":"SM Solano","year":"2000","unstructured":"Solano SM, Miller DW, Augood SJ, Young AB, Penney JB Jr (2000) Expression of alpha-synuclein, parkin, and ubiquitin carboxy-terminal hydrolase L1 mRNA in human brain: genes associated with familial Parkinson's disease. Ann Neurol 47(2):201\u2013210","journal-title":"Ann Neurol"},{"issue":"11","key":"730_CR108","doi-asserted-by":"publisher","first-page":"6469","DOI":"10.1073\/pnas.95.11.6469","volume":"95","author":"MG Spillantini","year":"1998","unstructured":"Spillantini MG, Crowther RA, Jakes R, Hasegawa M, Goedert M (1998) Alpha-Synuclein in filamentous inclusions of Lewy bodies from Parkinson's disease and dementia with lewy bodies. Proc Natl Acad Sci U S A 95(11):6469\u20136473","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"6645","key":"730_CR109","doi-asserted-by":"publisher","first-page":"839","DOI":"10.1038\/42166","volume":"388","author":"MG Spillantini","year":"1997","unstructured":"Spillantini MG, Schmidt ML, Lee VM, Trojanowski JQ, Jakes R, Goedert M (1997) Alpha-synuclein in Lewy bodies. Nature 388(6645):839\u2013840","journal-title":"Nature"},{"issue":"2","key":"730_CR110","doi-asserted-by":"publisher","first-page":"954","DOI":"10.1016\/j.ajpath.2011.04.013","volume":"179","author":"N Stefanova","year":"2011","unstructured":"Stefanova N, Fellner L, Reindl M, Masliah E, Poewe W, Wenning GK (2011) Toll-like receptor 4 promotes \u03b1-synuclein clearance and survival of nigral dopaminergic neurons. Am J Pathol 179(2):954\u2013963","journal-title":"Am J Pathol"},{"issue":"4","key":"730_CR111","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1007\/s12640-011-9294-3","volume":"21","author":"N Stefanova","year":"2012","unstructured":"Stefanova N, Georgievska B, Eriksson H, Poewe W, Wenning GK (2012) Myeloperoxidase inhibition ameliorates multiple system atrophy-like degeneration in a transgenic mouse model. Neurotox Res 21(4):393\u2013404","journal-title":"Neurotox Res"},{"issue":"1","key":"730_CR112","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1007\/s00401-012-0977-5","volume":"124","author":"N Stefanova","year":"2012","unstructured":"Stefanova N, Kaufmann WA, Humpel C, Poewe W, Wenning GK (2012) Systemic proteasome inhibition triggers neurodegeneration in a transgenic mouse model expressing human \u03b1-synuclein under oligodendrocyte promoter: implications for multiple system atrophy. Acta Neuropathol 124(1):51\u201365","journal-title":"Acta Neuropathol"},{"issue":"2","key":"730_CR113","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1007\/s00401-003-0717-y","volume":"106","author":"N Stefanova","year":"2003","unstructured":"Stefanova N, Puschban Z, Fernagut PO, Brouillet E, Tison F, Reindl M et al (2003) Neuropathological and behavioral changes induced by various treatment paradigms with MPTP and 3-nitropropionic acid in mice: towards a model of striatonigral degeneration (multiple system atrophy). Acta Neuropathol 106(2):157\u2013166","journal-title":"Acta Neuropathol"},{"issue":"3","key":"730_CR114","doi-asserted-by":"publisher","first-page":"869","DOI":"10.1016\/S0002-9440(10)62307-3","volume":"166","author":"N Stefanova","year":"2005","unstructured":"Stefanova N, Reindl M, Neumann M, Haass C, Poewe W, Kahle PJ, Wenning GK (2005) Oxidative stress in transgenic mice with oligodendroglial alpha-synuclein overexpression replicates the characteristic neuropathology of multiple system atrophy. Am J Pathol 166(3):869\u2013876","journal-title":"Am J Pathol"},{"issue":"15","key":"730_CR115","doi-asserted-by":"publisher","first-page":"2196","DOI":"10.1002\/mds.21671","volume":"22","author":"N Stefanova","year":"2007","unstructured":"Stefanova N, Reindl M, Neumann M, Kahle PJ, Poewe W, Wenning GK (2007) Microglial activation mediates neurodegeneration related to oligodendroglial alpha-synucleinopathy: implications for multiple system atrophy. Mov Disord 22(15):2196\u20132203","journal-title":"Mov Disord"},{"issue":"11","key":"730_CR116","doi-asserted-by":"publisher","first-page":"1690","DOI":"10.1016\/j.neurobiolaging.2007.04.006","volume":"29","author":"X Su","year":"2008","unstructured":"Su X, Maguire-Zeiss KA, Giuliano R, Prifti L, Venkatesh K, Federoff HJ (2008) Synuclein activates microglia in a model of Parkinson's disease. Neurobiol Aging 29(11):1690\u20131701","journal-title":"Neurobiol Aging"},{"key":"730_CR117","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1016\/j.nbd.2012.08.017","volume":"49","author":"K Tanji","year":"2013","unstructured":"Tanji K, Odagiri S, Maruyama A, Mori F, Kakita A, Takahashi H, Wakabayashi K (2013) Alteration of autophagosomal proteins in the brain of multiple system atrophy. Neurobiol Dis 49:190\u2013198","journal-title":"Neurobiol Dis"},{"issue":"6","key":"730_CR118","doi-asserted-by":"publisher","first-page":"2054","DOI":"10.1016\/j.celrep.2014.05.033","volume":"7","author":"HT Tran","year":"2014","unstructured":"Tran HT, Chung CH, Iba M, Zhang B, Trojanowski JQ, Luk KC, Lee VM (2014) \u0391-synuclein immunotherapy blocks uptake and templated propagation of misfolded \u03b1-synuclein and neurodegeneration. Cell Rep 7(6):2054\u20132065","journal-title":"Cell Rep"},{"issue":"6","key":"730_CR119","doi-asserted-by":"publisher","first-page":"628","DOI":"10.1007\/s004010051173","volume":"99","author":"K Tsuchiya","year":"2000","unstructured":"Tsuchiya K, Ozawa E, Haga C, Watabiki S, Ikeda M, Sano M et al (2000) Constant involvement of the Betz cells and pyramidal tract in multiple system atrophy: a clinicopathological study of seven autopsy cases. Acta Neuropathol 99(6):628\u2013636","journal-title":"Acta Neuropathol"},{"issue":"12","key":"730_CR120","doi-asserted-by":"publisher","first-page":"2728","DOI":"10.1002\/jnr.22089","volume":"87","author":"K Ubhi","year":"2009","unstructured":"Ubhi K, Lee PH, Adame A, Inglis C, Mante M, Rockenstein E et al (2009) Mitochondrial inhibitor 3-nitroproprionic acid enhances oxidative modification of alpha-synuclein in a transgenic mouse model of multiple system atrophy. J Neurosci Res 87(12):2728\u20132739","journal-title":"J Neurosci Res"},{"issue":"11","key":"730_CR121","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1016\/j.tins.2011.08.003","volume":"34","author":"K Ubhi","year":"2011","unstructured":"Ubhi K, Low P, Masliah E (2011) Multiple system atrophy: a clinical and neuropathological perspective. Trends Neurosci 34(11):581\u2013590","journal-title":"Trends Neurosci"},{"issue":"18","key":"730_CR122","doi-asserted-by":"publisher","first-page":"6236","DOI":"10.1523\/JNEUROSCI.0567-10.2010","volume":"30","author":"K Ubhi","year":"2010","unstructured":"Ubhi K, Rockenstein E, Mante M, Inglis C, Adame A, Patrick C et al (2010) Neurodegeneration in a transgenic mouse model of multiple system atrophy is associated with altered expression of oligodendroglial-derived neurotrophic factors. J Neurosci 30(18):6236\u20136246","journal-title":"J Neurosci"},{"issue":"1","key":"730_CR123","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1111\/nan.12312","volume":"42","author":"E Valera","year":"2016","unstructured":"Valera E, Monzio Compagnoni G, Masliah E (2016) Review: novel treatment strategies targeting alpha-synuclein in multiple system atrophy as a model of synucleinopathy. Neuropathol Appl Neurobiol 42(1):95\u2013106","journal-title":"Neuropathol Appl Neurobiol"},{"key":"730_CR124","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1186\/s40478-016-0409-1","volume":"5","author":"E Valera","year":"2017","unstructured":"Valera E, Spencer B, Fields JA, Trinh I, Adame A, Mante M et al (2017) Combination of alpha-synuclein immunotherapy with anti-inflammatory treatment in a transgenic mouse model of multiple system atrophy. Acta Neuropathol Commun 5:2","journal-title":"Acta Neuropathol Commun"},{"key":"730_CR125","doi-asserted-by":"publisher","first-page":"329","DOI":"10.3389\/fnmol.2017.00329","volume":"10","author":"E Valera","year":"2017","unstructured":"Valera E, Spencer B, Mott J, Trejo M, Adame A, Mante M et al (2017) MicroRNA-101 modulates autophagy and Oligodendroglial alpha-Synuclein accumulation in multiple system atrophy. Front Mol Neurosci 10:329","journal-title":"Front Mol Neurosci"},{"key":"730_CR126","doi-asserted-by":"publisher","first-page":"437","DOI":"10.3389\/fncel.2015.00437","volume":"9","author":"BDM Vieira","year":"2015","unstructured":"Vieira BDM, Radford RA, Chung RS, Guillemin GJ, Pountney DL (2015) Neuroinflammation in multiple system atrophy: response to and cause of \u03b1-Synuclein aggregation. Front Cell Neurosci 9:437","journal-title":"Front Cell Neurosci"},{"issue":"43","key":"730_CR127","doi-asserted-by":"publisher","first-page":"17797","DOI":"10.1073\/pnas.1113260108","volume":"108","author":"W Wang","year":"2011","unstructured":"Wang W, Perovic I, Chittuluru J, Kaganovich A, Nguyen LT, Liao J et al (2011) A soluble \u03b1-synuclein construct forms a dynamic tetramer. Proc Natl Acad Sci U S A 108(43):17797\u201317802","journal-title":"Proc Natl Acad Sci U S A"},{"key":"730_CR128","doi-asserted-by":"publisher","first-page":"1070","DOI":"10.1093\/brain\/awf117","volume":"125","author":"H Watanabe","year":"2002","unstructured":"Watanabe H, Saito Y, Terao S, Ando T, Kachi T, Mukai E et al (2002) Progression and prognosis in multiple system atrophy: an analysis of 230 Japanese patients. Brain 125(Pt 5:1070\u20131083","journal-title":"Brain"},{"issue":"2","key":"730_CR129","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1002\/mds.870120203","volume":"12","author":"GK Wenning","year":"1997","unstructured":"Wenning GK, Tison F, Ben Shlomo Y, Daniel SE, Quinn NP (1997) Multiple system atrophy: a review of 203 pathologically proven cases. Mov Disord 12(2):133\u2013147","journal-title":"Mov Disord"},{"issue":"12","key":"730_CR130","doi-asserted-by":"publisher","first-page":"4967","DOI":"10.1523\/JNEUROSCI.23-12-04967.2003","volume":"23","author":"A Wilkins","year":"2003","unstructured":"Wilkins A, Majed H, Layfield R, Compston A, Chandran S (2003) Oligodendrocytes promote neuronal survival and axonal length by distinct intracellular mechanisms: a novel role for oligodendrocyte-derived glial cell line-derived neurotrophic factor. J Neurosci 23(12):4967\u20134974","journal-title":"J Neurosci"},{"issue":"2","key":"730_CR131","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1073\/pnas.1719369115","volume":"115","author":"AL Woerman","year":"2018","unstructured":"Woerman AL, Kazmi SA, Patel S, Aoyagi A, Oehler A, Widjaja K et al (2018) Familial Parkinson's point mutation abolishes multiple system atrophy prion replication. Proc Natl Acad Sci U S A 115(2):409\u2013414","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1","key":"730_CR132","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1007\/s00401-017-1762-2","volume":"135","author":"AL Woerman","year":"2018","unstructured":"Woerman AL, Kazmi SA, Patel S, Freyman Y, Oehler A, Aoyagi A et al (2018) MSA prions exhibit remarkable stability and resistance to inactivation. Acta Neuropathol 135(1):49\u201363","journal-title":"Acta Neuropathol"},{"issue":"3","key":"730_CR133","doi-asserted-by":"publisher","first-page":"1045","DOI":"10.1074\/jbc.RA118.004471","volume":"294","author":"TR Yamasaki","year":"2019","unstructured":"Yamasaki TR, Holmes BB, Furman JL, Dhavale DD, Su BW, Song ES et al (2019) Parkinson's disease and multiple system atrophy have distinct \u03b1-synuclein seed characteristics. J Biol Chem 294(3):1045\u20131058","journal-title":"J Biol Chem"},{"issue":"6","key":"730_CR134","doi-asserted-by":"publisher","first-page":"847","DOI":"10.1016\/j.neuron.2005.01.032","volume":"45","author":"I Yazawa","year":"2005","unstructured":"Yazawa I, Giasson BI, Sasaki R, Zhang B, Joyce S, Uryu K et al (2005) Mouse model of multiple system atrophy alpha-synuclein expression in oligodendrocytes causes glial and neuronal degeneration. Neuron 45(6):847\u2013859","journal-title":"Neuron"},{"issue":"3","key":"730_CR135","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1007\/s10072-015-2414-8","volume":"37","author":"Q Zhao","year":"2016","unstructured":"Zhao Q, Yang X, Tian S, An R, Zheng J, Xu Y (2016) Association of the COQ2 V393A variant with risk of multiple system atrophy in east Asians: a case-control study and meta-analysis of the literature. Neurol Sci 37(3):423\u2013430","journal-title":"Neurol Sci"}],"container-title":["Acta Neuropathologica Communications"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s40478-019-0730-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s40478-019-0730-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s40478-019-0730-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,7,10]],"date-time":"2020-07-10T23:23:41Z","timestamp":1594423421000},"score":1,"resource":{"primary":{"URL":"https:\/\/actaneurocomms.biomedcentral.com\/articles\/10.1186\/s40478-019-0730-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,7,12]]},"references-count":135,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["730"],"URL":"https:\/\/doi.org\/10.1186\/s40478-019-0730-6","relation":{},"ISSN":["2051-5960"],"issn-type":[{"value":"2051-5960","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,7,12]]},"assertion":[{"value":"24 March 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 April 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 July 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not applicable.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"113"}}